Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein antibody, protein, ELISA kits.

Edit 
Antigenic SpecificitySevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein
Clonemonoclonal
Host SpeciesChimeric Human/Mouse
Reactive Speciesn/a
IsotypeIgG1
Formatfluorescein (FITC) conjugate
Size50 µl, 100 µl,
Concentration0.25 mg/ml
ApplicationsELISA
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Protein antibody is a chimaeric recombinant antibody conjugated to FITC for the detection of SARS-CoV-2/COVID-19 NP. This antibody is expressed in HEK293 cells and contains Mouse scFv and C-terminal Human IgG1 Fc tag.

The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus' ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.
Immunogenabx600062 - Recombinant SARS-CoV-2 Nucleoprotein (1-419 AA) expressed in Mammalian cells
Other NamesSevere Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2, COVID-19, 2019-nCoV, 2019 novel coronavirus, COVID19, SARS-CoV-2 NP, SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, Severe Acute Respiratory Syndrome Coronavirus 2, Severe Acute Respiratory Syndrome Coronavirus 2 , Severe Acute Respiratory Syndrome Coronavirus 2 , Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2, SARS-CoV-2 , SARS-CoV-2 , SARS-CoV-2, COVID-19, COVID-19 , COVID-19 , COVID-19, 2019-nCoV, 2019-nCoV , 2019-nCoV , 2019-nCoV, 2019 novel coronavirus, 2019 novel coronavirus , 2019 novel coronavirus , 2019 novel coronavirus, COVID19, COVID19 , COVID19 , COVID19, SARS-CoV-2 NP, SARS-CoV-2 NP , SARS-CoV-2 NP , SARS-CoV-2 NP, SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleocapsid , SARS-CoV-2 Nucleocapsid , SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, SARS-CoV-2 Nucleoprotein , SARS-CoV-2 Nucleoprotein , SARS-CoV-2 Nucleoprotein
Gene, Accession #N, Gene ID: 43740575, UniProt: P0DTC9
Catalog #abx243134
Priceplease inquire
Order / More InfoSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleocapsid Protein Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.